A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy
The study hypothesis is that XOMA 052 improves glycemic control in subjects with Type 2 Diabetes.
Study X052078 is designed to establish efficacious dose(s) for future studies based on improvement in HbA1c.
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply
Walunt Creek, California, United States
Lynhurst, Ohio, United States